[Management of soft-tissue rheumatism using a indomethacin-dexa-methasone (Deca-amuno) conbination].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001170:Arthritis, Infectious / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D020968:Brachial Plexus Neuritis / Q000188:drug therapy; D003907:Dexamethasone / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D006073:Gout / Q000188:drug therapy; D006621:Hip Joint; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use*; D007405:Intervertebral Disc Displacement / Q000188:drug therapy; D007719:Knee Joint; D008297:Male; D008875:Middle Aged; D010003:Osteoarthritis / Q000188:drug therapy; D010489:Periarthritis / Q000188:drug therapy; D012216:Rheumatic Diseases / Q000188:drug therapy*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy; D052256:Tendinopathy / Q000188:drug therapy
D004338:Drug Combinations; D003907:Dexamethasone; D007213:Indomethacin
Die Behandlung des Weichteilrheumatismus mit Indometacin-Dexamethason (Deca-Amuno.